Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Solventum Corporation Common Stock (NY:SOLV)

86.14 +0.37 (+0.43%)
Official Closing Price Updated: 7:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Solventum Corporation Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Q1 Rundown: Solventum (NYSE:SOLV) Vs Other Surgical Equipment & Consumables - Diversified Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Solventum (NYSE:SOLV) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
3 Healthcare Stocks Skating on Thin Ice
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
News headline image
2 Profitable Stocks Worth Investigating and 1 to Be Wary Of
A company with profits isn’t always a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
Via StockStory
News headline image
Firing on All Cylinders: CONMED (NYSE:CNMD) Q1 Earnings Lead the Way
Looking back on surgical equipment & consumables - diversified stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including CONMED (NYSE:CNMD) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
What Analysts Are Saying About Solventum Stock ↗
 
Via Benzinga
News headline image
Assessing Solventum: Insights From 9 Financial Analysts ↗
 
Via Benzinga
News headline image
What's going on in today's session: S&P500 movers ↗
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
News headline image
Which S&P500 stocks are gapping on Wednesday? ↗
Looking for the S&P500 stocks that are experiencing notable gaps on Wednesday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session. 
Via Chartmill
News headline image
3 of Wall Street’s Favorite Stocks Walking a Fine Line
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
Topics Economy
News headline image
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides... 
Via StockStory
Topics Government Stocks World Trade
News headline image
Stay informed with the top movers within the S&P500 index on Friday. ↗
Get insights into the S&P500 index performance on Friday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
News headline image
What's going on in today's session: S&P500 movers ↗
Let's delve into the developments on the US markets in the middle of the day on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
News headline image
Solventum (NYSE:SOLV) Exceeds Q1 Expectations
Healthcare solutions provider Solventum (NYSE:SOLV) announced better-than-expected revenue in Q1 CY2025, with sales up 2.7% year on year to $2.07 billion. Its non-GAAP profit of $1.34 per share was... 
Via StockStory
News headline image
Wall Street Mixed Ahead Of Fed Meeting, Alphabet Sinks: What's Driving Markets Wednesday? ↗
U.S. stocks traded mixed at midday Wednesday, as investors remained cautious ahead of the Federal Reserve’s upcoming policy decision, with Chair Jerome Powell set to speak at 2:30 p.m. ET. 
Via Benzinga
Topics Economy
News headline image
Solventum Earnings: What To Look For From SOLV
Healthcare solutions provider Solventum (NYSE:SOLV) will be reporting earnings tomorrow after market close. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
News headline image
7 Analysts Assess Solventum: What You Need To Know ↗
 
Via Benzinga
News headline image
3 Cash-Producing Stocks Walking a Fine Line
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
News headline image
Alpha Buying: Big Oil Becomes Ground Zero for Activist Investing in 2025 ↗
 
Via Benzinga
News headline image
Thermo Fisher Scientific Q1 Earnings Surpass Estimates, CEO Touts 'Strong Performance' Despite Economic Uncertainty ↗
Thermo Fisher topped Q1 estimates with $5.15 EPS and $10.36 billion revenue, boosted by diagnostics and life sciences growth. 
Via Benzinga
News headline image
Which S&P500 stocks have an unusual volume on Thursday? ↗
Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below. 
Via Chartmill
News headline image
Surgical Equipment & Consumables - Diversified Stocks Q4 Recap: Benchmarking STERIS (NYSE:STE)
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including STERIS... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Reflecting On Surgical Equipment & Consumables - Diversified Stocks’ Q4 Earnings: Zimmer Biomet (NYSE:ZBH)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Zimmer Biomet (NYSE:ZBH) and the best and... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
3M Spin Off Solventum Targets Higher Margins, EPS Growth In 2025-2028 Strategy ↗
Solventum detailed its 2025-2028 growth strategy, reaffirmed its 2025 guidance, and reported Q4 earnings that topped expectations with strong sales and EPS. 
Via Benzinga
News headline image
Q4 Earnings Outperformers: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - diversified stocks fared... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Solventum (SOLV): Buy, Sell, or Hold Post Q4 Earnings?
Solventum has been treading water for the past six months, recording a small return of 2.6% while holding steady at $74.01. 
Via StockStory
News headline image
BD (NYSE:BDX): Strongest Q4 Results from the Surgical Equipment & Consumables - Diversified Group
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including BD (NYSE:BDX)... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Here's What 3M's Big News Means to Investors ↗
Via The Motley Fool
News headline image
Surgical Equipment & Consumables - Diversified Stocks Q4 Highlights: CONMED (NYSE:CNMD)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at CONMED (NYSE:CNMD) and the best and worst... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Is 3M Stock a Buy Now? ↗
The manufacturing conglomerate is slowly turning a corner. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.